About Precision Medicine Advisors
What we do
We develop and deliver online and live educational programs for health care providers, consumers and others in the precision medicine ecosystem.
Our programs are crafted to meet the needs of busy professionals who want to learn the essentials of precision medicine or gain skills for implementing precision medicine into practice.
Our workshops and webinars are hands-on and interactive and closely track the rapidly evolving field of genomics and precision medicine.
We also advise companies on technical and strategic aspects of precision medicine.
Who we are
Precision Medicine Advisors was launched to serve a growing need in the health care field: giving health care providers the knowledge and skills to utilize precision medicine in their clinical practice.
We are experts in clinical applications of genomics who believe that for precision medicine to take hold, health care providers need increased awareness, a base of genomic literacy and practical skills to implement genetic testing.
PMA specializes in communicating precision medicine to lay professional audiences, providing scientifically sound, unbiased information to promote the responsible use of genomics in medicine.
Precision Medicine Advisors was launched to serve an unmet need in the health care field. We are a group of academics who provide customized educational programs around genomic and precision medicine to health care providers, academic institutions, industry, and other stakeholders.
While there are a lot of free educational materials out there, most are not appropriate for a lay professional audience with limited background in genomics. Our programs are crafted to meet the needs of busy professionals who want to learn the basics of precision medicine or gain practical skills for implementing precision medicine into practice.
We provide an interactive learning experience through live workshops, seminars, webinars and mini-courses.
Jeanette McCarthy, MPH, PhD is a UC Berkeley trained genetic epidemiologist and spent the early part of her career in industry at Millennium Pharmaceuticals before transitioning to academia. She currently holds adjunct faculty positions at UCSF and Duke University. Her previous research had focused on the genetic underpinnings of complex diseases, both infectious and chronic. More recently, she has become a leading educator in the field of genomic and precision medicine. Jeanette helped launch the first consumer-facing magazine in this field, Genome, and served as Editor-in-Chief from 2014-2016. She developed the first MOOC on precision medicine, offered through Coursera, and teaches at UCSF and UC Berkeley Extension as well. Jeanette is coauthor of the book, Precision Medicine: A Guide to Genomics in Clinical Practice (from McGraw Hill Education).
Connect with Jeanette on Linked In.
Vice President of Business Development
Shervin Kamkar is a business development and market strategy leader with over 15 years' experience in the genomics, life sciences, and diagnostics space. Most recently he was at Illumina, the market leader in next generation sequencing, where he was Commercial Business Head for the Understand Your Genome® (UYG) symposia - Illumina’s innovative, clinically responsible, experiential education program; the first and only of its kind allowing early adopters of precision medicine and personal genomics the opportunity to experience clinical whole genome sequencing from a position of first-hand experience.
Shervin is also co-founder and partner of the strategy and design consulting agency Kinetic, which serves health systems and digital health companies looking to penetrate the genomics markets. He has joined Precision Medicine Advisors as Vice President of Business Development, where his experience and passion will expand our physician education initiatives into live workshops.
Shervin holds a Bachelors degree in Microbiology from the University of California, Santa Barbara and a Masters degree in Molecular Biology from San Francisco State University and the University of California, San Francisco, where his research and thesis were focused on the identification and characterization of tumor suppressor genes in prostate cancer.
Connect with Shervin on Linked In.